| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/30/2001 | EP1102528A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
| 05/30/2001 | EP0925067A4 Composition and method for repairing neurological tissue |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297484A Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 05/30/2001 | CN1297483A Human protease and use of such protease for pharmaceutical applications and for reducing allergenicity of non-human proteins |
| 05/30/2001 | CN1297480A Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 05/30/2001 | CN1297477A Human spinal cord cell lines and methods of use therefor |
| 05/30/2001 | CN1297042A Method for preparing biocompatible supporter, and supporter prepared thereby |
| 05/30/2001 | CN1066487C Gene identifying sterile plant cytoplasm and process for preparing hybrid plant by using same |
| 05/29/2001 | US6239331 Enhancement of tomato phytoene synthase gene expression with a modified DNA |
| 05/29/2001 | US6239330 Fumonisin detoxification compositions and methods |
| 05/29/2001 | US6239329 Shoot meristem specific promoter sequences |
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6239259 Multivalent and multispecific antigen-binding protein |
| 05/29/2001 | US6239109 Method of promoting erythropoiesis |
| 05/29/2001 | US6238922 In vitro proliferation of neurons; dissociate brain tissue in suspension, propagate suspension, incubate with enzymes, isolate neuronal tissue and propagate in nutrients |
| 05/29/2001 | US6238920 Propagating preferential cells after incubation in mercaptoethanol |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238894 Culture product of helicobacter; catalyst |
| 05/29/2001 | US6238893 Method for intracellular DNA amplification |
| 05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders |
| 05/29/2001 | US6238891 Amplification of transcription and recovery of consequent protein in mammalian cells; mix suppressor solute and propagating cells in solution, recover and purify protein from cell culture |
| 05/29/2001 | US6238887 Ribosome recycling factor (FRR) of Staphylococcus aureus |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238881 Nucleotide sequence which codes for p115 rho-guanine exchange factor involved in cell signalling; therapeutics; diagnostics; recombinant culture production; antibodies; probes |
| 05/29/2001 | US6238873 Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof |
| 05/29/2001 | US6238858 Producing secondary virus such as togavirus or retrovirus in producer host cell for subsequent infection of target cells by using chimeric primary virus or combination which direct production in the host cells; gene therapy |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238664 Process for stabilizing proteins |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036650A2 An oncolytic adenovirus |
| 05/25/2001 | WO2001036648A1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036639A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036629A1 Transfer compounds, the production and the use thereof |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036619A2 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/25/2001 | WO2001036616A2 Acid nucleic construct bearing a system regulating the expression of a gene |
| 05/25/2001 | WO2001036615A2 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036595A2 Methods for conditional transgene expression and trait removal in plants |
| 05/25/2001 | WO2001036589A2 Human ex vivo immune system |
| 05/25/2001 | WO2001036489A2 Erythropoietin forms with improved properties |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036485A2 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036482A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036471A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | WO2001036467A2 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | WO2001036463A2 Genes specifically expressed in human dendritic cells |
| 05/25/2001 | WO2001036462A2 Protein c derivatives |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035990A2 Method for enhancing t cell reactivity toward tumour antigens |
| 05/25/2001 | WO2001035989A2 Use of anti-idiotypical antibodies as vaccines against cancer |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035969A1 T-cells specific for polymorphic proteins on malignant cells |
| 05/25/2001 | WO2001035968A1 Methods for inducing chondrogenesis and producing de novo cartilage in vitro |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001035734A1 An improved method for production of porcine clone embryos via somatic cell nuclear transfer |
| 05/25/2001 | WO2001035733A1 Method of acquiring immunological tolerance |
| 05/25/2001 | WO2001005942A3 Improved keratinocyte culture and uses thereof |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000075190A3 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO2000047750B1 Metalloproteases of the neprilysin family |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | CA2794123A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2685349A1 Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |